The Top 10 bestselling patented medicines in Canada for 2017. Janssen sold CND 938.1 million of its Remicade treatment for gastroenterology, rheumatology and dermatology indications, making up a full 5.6% of all patented medicine sales in Canada. In second place was Abbvie’s Humira with CND 701.9 million of sales and Gilead’s Epclusa with CND 518.2 million.